Chemours Co (CC) financials: revenue, earnings and cash flow
Fiscal 2017–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
Chemours Co’s revenue went from $6.2B in fiscal 2017 to $5.8B in fiscal 2025, a decline of about 0.8% a year.
Net income in fiscal 2025 was -$386M, a net margin of -6.6%; the best year in this period was 2018 with $995M.
Over the twelve months to September 30, 2026, revenue was $5.8B and net income -$154M.
Free cash flow was $51M in fiscal 2025 and positive in 8 of the 9 years shown.
The diluted share count fell 21% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.8B | $5.8B | $5.8B | $6.1B | $6.8B | $6.3B | $5.0B | $5.5B | $6.6B | $6.2B |
| Gross profit | $885M | $902M | $1.1B | $1.3B | $1.6B | $1.4B | $1.1B | $1.1B | $2.0B | $1.7B |
| Operating income | $406M | -$8M | $369M | -$110M | $904M | $861M | $389M | $84M | $1.4B | $1.1B |
| Net income | -$154M | -$386M | $69M | -$253M | $578M | $608M | $219M | -$52M | $995M | $746M |
| EPS (diluted) | $-1.02 | $-2.57 | $0.46 | $-1.70 | $3.65 | $3.60 | $1.32 | $-0.32 | $5.45 | $3.91 |
| R&D | $104M | $108M | $109M | $108M | $118M | $107M | $93M | $80M | $82M | $81M |
| Revenue growth | — | +0.4% | −4.9% | −11.0% | +7.7% | +27.7% | −10.1% | −16.8% | +7.4% | — |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $400M | $264M | -$633M | $556M | $755M | $814M | $807M | $650M | $1.1B | $640M |
| Capital spending | -$189M | -$213M | -$360M | -$370M | -$307M | -$277M | -$267M | -$481M | -$498M | -$411M |
| Free cash flow | $211M | $51M | -$993M | $186M | $448M | $537M | $540M | $169M | $642M | $229M |
| Dividends paid | $54M | $78M | $148M | $149M | $154M | $164M | $164M | $164M | $148M | $22M |
| Buybacks | — | — | — | $69M | $495M | $173M | $0 | $322M | $644M | $106M |
| Stock-based pay | $22M | $21M | $15M | $18M | $27M | $34M | $16M | $19M | $24M | $29M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $670M | $713M | $1.2B | $1.1B | $1.5B | $1.1B | $943M | $1.2B | $1.6B |
| Debt | — | $4.4B | $4.4B | $4.3B | $3.9B | $4.0B | $4.3B | $4.5B | $4.0B | $4.2B |
| Equity | — | $250M | $571M | $721M | $1.1B | $1.1B | $813M | $689M | $1.0B | $860M |
| Total assets | — | $7.4B | $7.5B | $8.2B | $7.6B | $7.5B | $7.1B | $7.3B | $7.4B | $7.3B |
| Shares (diluted) | 152M | 150M | 150M | 149M | 158M | 169M | 166M | 165M | 183M | 191M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 15.2% | 15.5% | 19.8% | 21.4% | 23.7% | 21.8% | 21.5% | 19.2% | 29.7% | 28.2% |
| Operating margin | 7.0% | -0.1% | 6.4% | -1.8% | 13.2% | 13.6% | 7.8% | 1.5% | 20.3% | 18.2% |
| Net margin | -2.6% | -6.7% | 1.2% | -4.2% | 8.5% | 9.6% | 4.4% | -0.9% | 15.0% | 12.1% |
| FCF margin | 3.6% | 0.9% | -17.2% | 3.1% | 6.6% | 8.5% | 10.9% | 3.1% | 9.7% | 3.7% |
| ROIC | — | -0.1% | 4.8% | -1.7% | 14.1% | 15.2% | 6.0% | 1.3% | 23.1% | 18.4% |
| ROE | — | -154.4% | 12.1% | -35.1% | 52.2% | 56.2% | 26.9% | -7.5% | 98.1% | 86.7% |
Frequently asked questions
What is Chemours Co’s annual revenue?
$5.8B in fiscal 2025 and $5.8B over the twelve months to September 30, 2026.
How much profit does Chemours Co make?
Net income was -$386M in fiscal 2025 (net margin -6.6%).
Is Chemours Co’s revenue growing?
Yes: revenue rose 0.4% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.